Furor therapeuticus: Benjamin Rush and the Philadelphia yellow fever epidemic of 1793

American Journal of Psychiatry

Volumn 164, Issue 4, 2007, Pages 552-555

  Eisenberg, Leon ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; DEXAMPHETAMINE; IMIPRAMINE; IPRONIAZID; LITHIUM; RESERPINE;

ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG COST; HUMAN; MENTAL DISEASE; NONHUMAN; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PSYCHOANALYSIS; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; REVIEW; UNSPECIFIED SIDE EFFECT; YELLOW FEVER;

EID: 34247525234     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.2007.164.4.552     Document Type: Review

References (26)

1. Corner GW (ed): The Autobiography of Benjamin Rush. Princeton, NJ, Princeton University Press, 1948
2. Rush B: Medical Inquiries and Observations Upon the Diseases of the Mind. Philadelphia, Kimber & Richardson, 1812 (reprinted New York, Hafner Publishing, 1962)
3. Powell JH: Bring Out Your Dead: The Great Plague of Yellow Fever in Philadelphia in 1793. Philadelphia, Charles EA Winslow, 1949
4. Pernick MS: Politics, parties, and pestilence: epidemic yellow fever in Philadelphia and the rise of the first party system. William and Mary Quarterly, 3rd Ser 1972; 29:559-586
5. Pernick MS: Politics, parties, and pestilence, in Sickness and Health in America. Edited by Leavitt JW, Numbers RL. Madison, University of Wisconsin Press, 1978, pp 241-256
6. Middleton WS: The yellow fever epidemic of 1793 in Philadelphia. Ann Med Hist 1928; 10:434-450
7. Klerman GL: The psychiatric revolution of the past 25 years, in Deviance and Mental Illness 6. Edited by Gove W. Beverly Hills, Calif, Sage Publications, 1982, 177-198
8. Gruenberg EM: The social breakdown syndrome - some origins. Am J Psychiatry 1967; 123:1481-1489
9. Shepherd M, Goodman N, Watt DC: The application of hospital statistics in the evaluation of pharmacotherapy in a psychiatric population. Compr Psychiatry 1961; 2:11-19
10. Odegaard O: Patterns of discharge from Norwegian psychiatric hospitals before and after the introduction of psychotropic drugs. Am J Psychiatry 1964; 120:772-778
11. Lieberman JA: Comparative effectiveness of antipsychotic drugs. Arch Gen Psychiatry 2006; 63:1069-1072
12. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK, the CATIE Investigators: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353:1209-1223
13. McEvoy JP, Lieberman JA, Stroup TS, Davis SM, Meltzer HY, Rosenheck RA, Swartz MS, Perkins DO, Keefe RS, Davis CD, Severe J, Hsiao JK, the CATIE Investigators: Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment. Am J Psychiatry 2006; 163:600-610
14. Rosenheck RA: Outcomes, costs, and policy caution: a commentary on the cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 12). Arch Gen Psychiatry 2006; 63:1074-1076
15. Jones PB, Barnes TR, Davies L, Dunn G, Lloyd H, Hayhurst KP, Murray RM, Markwick A, Lewis SW: Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry 2006; 63:1079-1087
16. Angell M: The Truth About the Drug Companies: How They Deceive Us and What to Do About It. New York, Random House, 2004
17. Avorn J: Powerful Medicines: The Benefits, Risks, and Costs of Prescription Drugs. New York, Knopf, 2004
18. Lipman RS: NIMH-PRB support of research in minimal brain dysfunction in children, in Clinical Use of Stimulant Drugs in Children: Proceedings of a Symposium Held at Key Biscayne, Fla, March 5-8, 1972. Edited by Conners CK. New York, American Elsevier Publishing, 1974, pp 202-213
19. Eisenberg L, Lachman R, Molling P, Lockner A, Mizelle J, Conners K: A psychopharmacologic study in a training school for delinquent boys. Am J Orthopsychiatry 1963; 33:431-447
20. Eisenberg L, Conners CK: The effect of a stimulant drug (methylphenidate) on symptomatology (impulsivity) and learning in disturbed children. Am J Psychiatry 1963; 120:458-464
21. Eisenberg L, Conners CK, Sharpe L: Effects of methylphenidate on symptomatology and learning in disturbed children. Am J Psychiatry 1963; 120:458-464
22. (reprinted as Effects of methylphenidate [Ritalin] on paired-associate learning and porteus maze performance in disturbed children. J Consult Psychol 1964; 28:14-22)
23. Rutter M, Lebovici S, Eisenberg L, Sneznevskij AV, Sadoun R, Brooke E, Lin TY: A tri-axial classification of mental disorders in childhood: an international study. J Child Psychol Psychiatry 1969; 10:41-61
24. Harris G: Proof is scant on psychiatric drug mix for youth. New York Times, Nov 23, 2006, A1
25. Eisenberg L: Is psychiatry more mindful or brainier than it was a decade ago? Br J Psychiatry 2000; 176:1-5
26. Lewis A: Ebb and flow in social psychiatry. Yale J Biol Med 1962; 35:62-83